DK527984D0 - 11-substituerede 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som antipsychotika og analgetika - Google Patents
11-substituerede 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som antipsychotika og analgetikaInfo
- Publication number
- DK527984D0 DK527984D0 DK527984A DK527984A DK527984D0 DK 527984 D0 DK527984 D0 DK 527984D0 DK 527984 A DK527984 A DK 527984A DK 527984 A DK527984 A DK 527984A DK 527984 D0 DK527984 D0 DK 527984D0
- Authority
- DK
- Denmark
- Prior art keywords
- antipsy
- benzoxazepines
- pyrrolo
- intermediates
- substituted
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- TYGBVOSJEFXEDH-UHFFFAOYSA-N 6,11-dihydropyrrolo[2,1-c][1,4]benzoxazepine Chemical class C1OC2=CC=CC=C2CN2C=CC=C12 TYGBVOSJEFXEDH-UHFFFAOYSA-N 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000000561 anti-psychotic effect Effects 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/549,098 US4608374A (en) | 1983-11-07 | 1983-11-07 | 11-substituted 5H,11H-pyrrolo[2,1-c][1,4]benzoxazepines as antipsychotic and analgesic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK527984D0 true DK527984D0 (da) | 1984-11-06 |
| DK527984A DK527984A (da) | 1985-05-08 |
Family
ID=24191656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK527984A DK527984A (da) | 1983-11-07 | 1984-11-06 | 11-substituerede 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som antipsychotika og analgetika |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4608374A (da) |
| EP (2) | EP0258612A1 (da) |
| JP (1) | JPS60115590A (da) |
| KR (1) | KR850003893A (da) |
| AT (1) | ATE47856T1 (da) |
| AU (2) | AU582553B2 (da) |
| CA (1) | CA1267893A (da) |
| DE (1) | DE3480399D1 (da) |
| DK (1) | DK527984A (da) |
| ES (4) | ES8608524A1 (da) |
| FI (1) | FI78103C (da) |
| GR (1) | GR80839B (da) |
| HU (1) | HU193233B (da) |
| IL (1) | IL73434A0 (da) |
| NO (1) | NO844423L (da) |
| NZ (1) | NZ210100A (da) |
| PH (1) | PH21257A (da) |
| PT (1) | PT79457B (da) |
| ZA (1) | ZA848655B (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4758559A (en) * | 1986-01-21 | 1988-07-19 | Ciba-Geigy Corporation | Pyrrolo[1,2-a] [4,1]benzoxazepine derivatives useful as calmodulin and histamine inhibitors |
| US4794110A (en) * | 1987-07-20 | 1988-12-27 | Hoechst-Roussel Pharmaceuticals, Inc. | 5-Aryl-11-substituted-5H,11H-pyrrolo[2,1-c][1,4]benzoxazepined as analgesic and hypotensive agents |
| US4865764A (en) * | 1987-07-20 | 1989-09-12 | Hoechst-Roussel Pharmaceuticals, Inc. | 5-aryl-11-substituted-5H,11H-pyrrolo[2,1-][1,4]benzoxazepines as hypotensive agents |
| US4812450A (en) * | 1987-07-30 | 1989-03-14 | Hoechst-Roussel Pharmaceuticals Inc. | Spiro((piperidine-pyrrolidine- or hexahydroazepinyl substituted) pyrrolo(2,1-C) (1,4)benzoxazepines) |
| US5015637A (en) * | 1990-05-25 | 1991-05-14 | Hoechst-Roussel Pharmaceutical Inc. | Pyrido[3,4-b]pyrrolo[1,2-e][1,4,5]oxadiazepines |
| GB9418326D0 (en) * | 1994-09-12 | 1994-11-02 | Lilly Industries Ltd | Pharmaceutical compounds |
| GB2308362A (en) * | 1995-12-19 | 1997-06-25 | Lilly Industries Ltd | Pharmaceutical indole derivatives |
| EP1554572B1 (en) | 2001-07-25 | 2009-10-14 | Raptor Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| JP4400441B2 (ja) | 2004-12-14 | 2010-01-20 | 三菱電機株式会社 | 半導体装置 |
| EP3827747A1 (en) | 2005-04-28 | 2021-06-02 | Otsuka Pharmaceutical Co., Ltd. | Pharma-informatics system |
| EP2063905B1 (en) | 2006-09-18 | 2014-07-30 | Raptor Pharmaceutical Inc | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
| GB0711776D0 (en) * | 2007-06-18 | 2007-07-25 | Syngenta Participations Ag | Substituted aromatic heterocyclic compounds as fungicides |
| NZ616673A (en) | 2009-02-20 | 2014-08-29 | To Bbb Holding B V | Glutathione-based drug delivery system |
| ES2942923T3 (es) | 2009-05-06 | 2023-06-07 | Laboratory Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4053599A (en) * | 1976-02-26 | 1977-10-11 | American Hoechst Corporation | Piperazionalkylpyrrolobenzoxazalkanes |
| US4045448A (en) * | 1976-02-26 | 1977-08-30 | American Hoechst Corporation | Pyrrolo[2,1-c][1,4]benzoxazepine and benzoxazocine derivatives |
| US4029672A (en) * | 1976-02-26 | 1977-06-14 | American Hoechst Corporation | Aminoalkylpyrrolobenzoxazalkanes |
| US4169095A (en) * | 1977-01-19 | 1979-09-25 | American Hoechst Corporation | Process for preparing aminoalkylpyrrolobenzoxazalkanes |
| US4169094A (en) * | 1977-01-19 | 1979-09-25 | American Hoechst Corporation | Process for preparing aminoalkylpyrrolobenzoxazalkanes |
| US4263438A (en) * | 1977-09-13 | 1981-04-21 | Pfizer Inc. | 3-[2,4-(Disubstituted)-phenyl]azacycloalkanones as analgesics |
| US4208417A (en) * | 1978-06-29 | 1980-06-17 | Pharmindustrie | Indole derivatives and their use as anxiolytics |
| GR73560B (da) * | 1979-02-24 | 1984-03-15 | Pfizer | |
| CA1211437A (en) * | 1981-08-12 | 1986-09-16 | Rene Borer | Benzazepines |
-
1983
- 1983-11-07 US US06/549,098 patent/US4608374A/en not_active Expired - Fee Related
-
1984
- 1984-10-31 HU HU844037A patent/HU193233B/hu not_active IP Right Cessation
- 1984-11-02 DE DE8484113181T patent/DE3480399D1/de not_active Expired
- 1984-11-02 EP EP87110724A patent/EP0258612A1/en not_active Withdrawn
- 1984-11-02 EP EP84113181A patent/EP0144729B1/en not_active Expired
- 1984-11-02 AT AT84113181T patent/ATE47856T1/de not_active IP Right Cessation
- 1984-11-05 GR GR80839A patent/GR80839B/el unknown
- 1984-11-05 IL IL73434A patent/IL73434A0/xx unknown
- 1984-11-05 PH PH31405A patent/PH21257A/en unknown
- 1984-11-05 AU AU35104/84A patent/AU582553B2/en not_active Ceased
- 1984-11-05 ES ES537369A patent/ES8608524A1/es not_active Expired
- 1984-11-05 FI FI844333A patent/FI78103C/fi not_active IP Right Cessation
- 1984-11-05 NZ NZ210100A patent/NZ210100A/xx unknown
- 1984-11-06 CA CA000467151A patent/CA1267893A/en not_active Expired - Lifetime
- 1984-11-06 PT PT79457A patent/PT79457B/pt unknown
- 1984-11-06 ZA ZA848655A patent/ZA848655B/xx unknown
- 1984-11-06 NO NO844423A patent/NO844423L/no unknown
- 1984-11-06 DK DK527984A patent/DK527984A/da not_active Application Discontinuation
- 1984-11-06 JP JP59232553A patent/JPS60115590A/ja active Pending
- 1984-11-07 KR KR1019840006971A patent/KR850003893A/ko not_active Application Discontinuation
-
1985
- 1985-07-30 ES ES545728A patent/ES8707538A1/es not_active Expired
-
1986
- 1986-01-31 ES ES551522A patent/ES8704950A1/es not_active Expired
- 1986-03-01 ES ES552578A patent/ES8707953A1/es not_active Expired
-
1989
- 1989-01-18 AU AU28565/89A patent/AU2856589A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| FI844333L (fi) | 1985-05-08 |
| ES8707953A1 (es) | 1987-09-16 |
| AU2856589A (en) | 1989-07-13 |
| AU3510484A (en) | 1985-05-16 |
| ZA848655B (en) | 1985-06-26 |
| DK527984A (da) | 1985-05-08 |
| GR80839B (en) | 1985-02-26 |
| ES8707538A1 (es) | 1987-08-01 |
| ES552578A0 (es) | 1987-09-16 |
| ES545728A0 (es) | 1987-08-01 |
| DE3480399D1 (en) | 1989-12-14 |
| ES8608524A1 (es) | 1986-06-16 |
| FI844333A0 (fi) | 1984-11-05 |
| KR850003893A (ko) | 1985-06-29 |
| EP0144729B1 (en) | 1989-11-08 |
| JPS60115590A (ja) | 1985-06-22 |
| PH21257A (en) | 1987-08-31 |
| PT79457A (en) | 1984-12-01 |
| PT79457B (en) | 1986-11-14 |
| EP0258612A1 (en) | 1988-03-09 |
| HUT36127A (en) | 1985-08-28 |
| FI78103B (fi) | 1989-02-28 |
| ES551522A0 (es) | 1987-04-16 |
| IL73434A0 (en) | 1985-02-28 |
| NZ210100A (en) | 1988-06-30 |
| NO844423L (no) | 1985-05-08 |
| ATE47856T1 (de) | 1989-11-15 |
| ES8704950A1 (es) | 1987-04-16 |
| ES537369A0 (es) | 1986-06-16 |
| US4608374A (en) | 1986-08-26 |
| AU582553B2 (en) | 1989-04-06 |
| CA1267893A (en) | 1990-04-17 |
| EP0144729A1 (en) | 1985-06-19 |
| HU193233B (en) | 1987-08-28 |
| FI78103C (fi) | 1989-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK365184D0 (da) | 1,8-naphthyridinderivater eller estre eller salte deraf, deres fremstilling og anvendelse som farmaceutika | |
| DK527984D0 (da) | 11-substituerede 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepiner eller farmaceutisk acceptable salte deraf, deres fremstilling og mellemprodukter hertil samt deres anvendelse som antipsychotika og analgetika | |
| DK568885D0 (da) | Sure indolforbindelser og deres anvendelse som antiallergiske midler | |
| DK519985D0 (da) | Quinoloncarboxylsyrederivater, fremgangsmaade til fremstilling deraf og antibakterielt middel indeholdende saadanne derivater | |
| DK521685D0 (da) | Spergualin-derivater og anvendelse deraf til fremstilling af laegemidler med immunosuppressiv virkning | |
| DK154385D0 (da) | Tetrahydrothienopyridiner eller farmaceutisk uskadelige salte deraf, deres fremstilling og anvendelse som laegemidler | |
| NO167286C (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater. | |
| NO853551L (no) | Fremgangsmaate ved fremstilling av prolinderivater og lignende forbindelser med antihypertensiv aktivitet. | |
| NO20000423D0 (no) | Tiazolobenzoheterocykler, deres fremstilling samt medikamenter inneholdende forbindelsene | |
| NO303829B1 (no) | Nye benzylalkoholderivater, mellomprodukter, farmas°ytiske preparater inneholdende de nye forbindelsene samt deres anvendelse | |
| DK364386A (da) | 1-alkyl-ergolinyl-thiourinstofderivater og fremgangsmaade til fremstilling deraf samt deres anvendelse | |
| DK0587048T3 (da) | Heteroarenylpiperaziner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler | |
| DK546386D0 (da) | Piperidinderivater eller salte deraf og deres anvendelse som farmaceutika | |
| DK400385A (da) | Arphameninderivater, fremgangsmaade til deres fremstilling samt anvendelse heraf som laegemiddel | |
| DK46884A (da) | 5-aminomethyl-imidazol-1-yl-1,3-dialkyl-1h-pyrazol-4-yl-aroyl-methanoner, fremgangsmaade til deres fremstilling samt deres anvendelse | |
| DK591884A (da) | Dibenz-(b,f)-oxepiner, deres fremstilling og anvendelse som laegemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ATS | Application withdrawn |